Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study
Endocrine. 2022 Aug;77(2):403-407.
doi: 10.1007/s12020-022-03109-5.
Epub 2022 Jun 21.
1 Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, NYU Grossman School of Medicine, New York, NY, 10016, USA. Brenda.Dorcely@nyulangone.org.
2 Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, NYU Grossman School of Medicine, New York, NY, 10016, USA.
3 Department of Population Health, NYU Grossman School of Medicine, New York, NY, 10016, USA.
4 Department of Endocrinology, Diabetes & Metabolism and Internal Medicine, Hawaii Permanente Medical Group, Honolulu, HI, 96814, USA.
5 Division of Hospital Medicine, Emory University School of Medicine, Atlanta, GA, 30322, USA.